scispace - formally typeset
Search or ask a question
Institution

Broad Institute

NonprofitCambridge, Massachusetts, United States
About: Broad Institute is a nonprofit organization based out in Cambridge, Massachusetts, United States. It is known for research contribution in the topics: Population & Genome-wide association study. The organization has 6584 authors who have published 11618 publications receiving 1522743 citations. The organization is also known as: Eli and Edythe L. Broad Institute of MIT and Harvard.


Papers
More filters
Posted ContentDOI
10 Jul 2017-bioRxiv
TL;DR: CERES, a computational method to estimate gene dependency levels from CRISPR-Cas9 essentiality screens while accounting for the copy-number-specific effect, as well as variable sgRNA activity, is developed and applied to sets of screens performed with different sgRNAs and found that it reduces false positive results and provides meaningful estimates of sg RNA activity.
Abstract: The CRISPR-Cas9 system has revolutionized gene editing both on single genes and in multiplexed loss-of-function screens, enabling precise genome-scale identification of genes essential to proliferation and survival of cancer cells. However, previous studies reported that an anti-proliferative effect of Cas9-mediated DNA cleavage confounds such measurement of genetic dependency, particularly in the setting of copy number gain. We performed genome-scale CRISPR-Cas9 essentiality screens on 342 cancer cell lines and found that this effect is common to all lines, leading to false positive results when targeting genes in copy number amplified regions. We developed CERES, a computational method to estimate gene dependency levels from CRISPR-Cas9 essentiality screens while accounting for the copy-number-specific effect, as well as variable sgRNA activity. We applied CERES to sets of screens performed with different sgRNA libraries and found that it reduces false positive results and provides meaningful estimates of sgRNA activity. As a result, the application of CERES improves confidence in the interpretation of genetic dependency data from CRISPR-Cas9 essentiality screens of cancer cell lines.

477 citations

Journal ArticleDOI
TL;DR: In this paper, the authors proposed a statistical method to estimate the ancestral origin of a locus on the basis of the composite genotypes of linked markers, and showed that this approach accurately estimates states of ancestral origin along the genome.
Abstract: Admixture mapping (also known as “mapping by admixture linkage disequilibrium,” or MALD) has been proposed as an efficient approach to localizing disease-causing variants that differ in frequency (because of either drift or selection) between two historically separated populations. Near a disease gene, patient populations descended from the recent mixing of two or more ethnic groups should have an increased probability of inheriting the alleles derived from the ethnic group that carries more disease-susceptibility alleles. The central attraction of admixture mapping is that, since gene flow has occurred recently in modern populations (e.g., in African and Hispanic Americans in the past 20 generations), it is expected that admixture-generated linkage disequilibrium should extend for many centimorgans. High-resolution marker sets are now becoming available to test this approach, but progress will require (a) computational methods to infer ancestral origin at each point in the genome and (b) empirical characterization of the general properties of linkage disequilibrium due to admixture. Here we describe statistical methods to estimate the ancestral origin of a locus on the basis of the composite genotypes of linked markers, and we show that this approach accurately estimates states of ancestral origin along the genome. We apply this approach to show that strong admixture linkage disequilibrium extends, on average, for 17 cM in African Americans. Finally, we present power calculations under varying models of disease risk, sample size, and proportions of ancestry. Studying ∼2,500 markers in ∼2,500 patients should provide power to detect many regions contributing to common disease. A particularly important result is that the power of an admixture mapping study to detect a locus will be nearly the same for a wide range of mixture scenarios: the mixture proportion should be 10%–90% from both ancestral populations.

476 citations

Journal ArticleDOI
Daniel E. Neafsey1, Robert M. Waterhouse, Mohammad Reza Abai2, Sergey Aganezov3, Max A. Alekseyev3, James E. Allen4, James Amon, Bruno Arcà5, Peter Arensburger6, Gleb N. Artemov7, Lauren A. Assour8, Hamidreza Basseri2, Aaron M. Berlin1, Bruce W. Birren1, Stéphanie Blandin9, Stéphanie Blandin10, Andrew I. Brockman11, Thomas R. Burkot12, Austin Burt11, Clara S. Chan13, Cedric Chauve14, Joanna C. Chiu15, Mikkel B. Christensen4, Carlo Costantini16, Victoria L.M. Davidson17, Elena Deligianni18, Tania Dottorini11, Vicky Dritsou19, Stacey Gabriel1, Wamdaogo M. Guelbeogo, Andrew Brantley Hall20, Mira V. Han21, Thaung Hlaing, Daniel S.T. Hughes4, Daniel S.T. Hughes22, Adam M. Jenkins23, Xiaofang Jiang20, Irwin Jungreis13, Evdoxia G. Kakani19, Evdoxia G. Kakani24, Maryam Kamali20, Petri Kemppainen25, Ryan C. Kennedy26, Ioannis K. Kirmitzoglou27, Ioannis K. Kirmitzoglou11, Lizette L. Koekemoer28, Njoroge Laban, Nicholas Langridge4, Mara K. N. Lawniczak11, Manolis Lirakis29, Neil F. Lobo8, Ernesto Lowy4, Robert M. MacCallum11, Chunhong Mao20, Gareth Maslen4, Charles Mbogo30, Jenny McCarthy6, Kristin Michel17, Sara N. Mitchell24, Wendy Moore31, Katherine A. Murphy15, Anastasia N. Naumenko20, Tony Nolan11, Eva Maria Novoa13, Samantha M. O’Loughlin11, Chioma Oringanje31, Mohammad Ali Oshaghi2, Nazzy Pakpour15, Philippos Aris Papathanos11, Philippos Aris Papathanos19, Ashley Peery20, Michael Povelones32, Anil Prakash33, David P. Price34, Ashok Rajaraman14, Lisa J. Reimer35, David C. Rinker36, Antonis Rokas37, Tanya L. Russell12, N’Fale Sagnon, Maria V. Sharakhova20, Terrance Shea1, Felipe A. Simão38, Felipe A. Simão39, Frédéric Simard16, Michel A. Slotman40, Pradya Somboon41, V. N. Stegniy7, Claudio J. Struchiner42, Claudio J. Struchiner43, Gregg W.C. Thomas44, Marta Tojo45, Pantelis Topalis18, Jose M. C. Tubio46, Maria F. Unger8, John Vontas29, Catherine Walton25, Craig S. Wilding47, Judith H. Willis48, Yi-Chieh Wu13, Yi-Chieh Wu49, Guiyun Yan50, Evgeny M. Zdobnov39, Evgeny M. Zdobnov38, Xiaofan Zhou37, Flaminia Catteruccia24, Flaminia Catteruccia19, George K. Christophides11, Frank H. Collins8, Robert S. Cornman48, Andrea Crisanti19, Andrea Crisanti11, Martin J. Donnelly46, Martin J. Donnelly35, Scott J. Emrich8, Michael C. Fontaine51, Michael C. Fontaine8, William M. Gelbart24, Matthew W. Hahn44, Immo A. Hansen34, Paul I. Howell52, Fotis C. Kafatos11, Manolis Kellis13, Daniel Lawson4, Christos Louis18, Shirley Luckhart15, Marc A. T. Muskavitch53, Marc A. T. Muskavitch23, José M. C. Ribeiro, Michael A. Riehle31, Igor V. Sharakhov20, Zhijian Tu20, Laurence J. Zwiebel37, Nora J. Besansky8 
Broad Institute1, Tehran University of Medical Sciences2, George Washington University3, European Bioinformatics Institute4, Sapienza University of Rome5, Temple University6, Tomsk State University7, University of Notre Dame8, French Institute of Health and Medical Research9, Centre national de la recherche scientifique10, Imperial College London11, James Cook University12, Massachusetts Institute of Technology13, Simon Fraser University14, University of California, Davis15, Institut de recherche pour le développement16, Kansas State University17, Foundation for Research & Technology – Hellas18, University of Perugia19, Virginia Tech20, University of Nevada, Las Vegas21, Baylor College of Medicine22, Boston College23, Harvard University24, University of Manchester25, University of California, San Francisco26, University of Cyprus27, National Health Laboratory Service28, University of Crete29, Kenya Medical Research Institute30, University of Arizona31, University of Pennsylvania32, Indian Council of Medical Research33, New Mexico State University34, Liverpool School of Tropical Medicine35, Vanderbilt University Medical Center36, Vanderbilt University37, University of Geneva38, Swiss Institute of Bioinformatics39, Texas A&M University40, Chiang Mai University41, Rio de Janeiro State University42, Oswaldo Cruz Foundation43, Indiana University44, University of Santiago de Compostela45, Wellcome Trust Sanger Institute46, Liverpool John Moores University47, University of Georgia48, Harvey Mudd College49, University of California, Irvine50, University of Groningen51, Centers for Disease Control and Prevention52, Biogen Idec53
02 Jan 2015-Science
TL;DR: The authors investigated the genomic basis of vectorial capacity and explore new avenues for vector control, sequenced the genomes of 16 anopheline mosquito species from diverse locations spanning ~100 million years of evolution Comparative analyses show faster rates of gene gain and loss, elevated gene shuffling on the X chromosome, and more intron losses, relative to Drosophila.
Abstract: Variation in vectorial capacity for human malaria among Anopheles mosquito species is determined by many factors, including behavior, immunity, and life history To investigate the genomic basis of vectorial capacity and explore new avenues for vector control, we sequenced the genomes of 16 anopheline mosquito species from diverse locations spanning ~100 million years of evolution Comparative analyses show faster rates of gene gain and loss, elevated gene shuffling on the X chromosome, and more intron losses, relative to Drosophila Some determinants of vectorial capacity, such as chemosensory genes, do not show elevated turnover but instead diversify through protein-sequence changes This dynamism of anopheline genes and genomes may contribute to their flexible capacity to take advantage of new ecological niches, including adapting to humans as primary hosts

476 citations

Journal ArticleDOI
23 Dec 2011-Cell
TL;DR: A Primer on these light-activated ion channels and pumps is provided, a group of opsins bridging prior categories are described, and the convergence of molecular engineering and genomic discovery for the utilization and understanding of these remarkable molecular machines are explored.

476 citations

Journal ArticleDOI
TL;DR: Results constitute evidence that, for many of the complex diseases studied here, common genetic associations implicate regions encoding proteins that physically interact in a preferential manner, in line with observations in Mendelian disease.
Abstract: Genome-wide association studies (GWAS) have defined over 150 genomic regions unequivocally containing variation predisposing to immune-mediated disease. Inferring disease biology from these observations, however, hinges on our ability to discover the molecular processes being perturbed by these risk variants. It has previously been observed that different genes harboring causal mutations for the same Mendelian disease often physically interact. We sought to evaluate the degree to which this is true of genes within strongly associated loci in complex disease. Using sets of loci defined in rheumatoid arthritis (RA) and Crohn's disease (CD) GWAS, we build protein-protein interaction (PPI) networks for genes within associated loci and find abundant physical interactions between protein products of associated genes. We apply multiple permutation approaches to show that these networks are more densely connected than chance expectation. To confirm biological relevance, we show that the components of the networks tend to be expressed in similar tissues relevant to the phenotypes in question, suggesting the network indicates common underlying processes perturbed by risk loci. Furthermore, we show that the RA and CD networks have predictive power by demonstrating that proteins in these networks, not encoded in the confirmed list of disease associated loci, are significantly enriched for association to the phenotypes in question in extended GWAS analysis. Finally, we test our method in 3 non-immune traits to assess its applicability to complex traits in general. We find that genes in loci associated to height and lipid levels assemble into significantly connected networks but did not detect excess connectivity among Type 2 Diabetes (T2D) loci beyond chance. Taken together, our results constitute evidence that, for many of the complex diseases studied here, common genetic associations implicate regions encoding proteins that physically interact in a preferential manner, in line with observations in Mendelian disease.

476 citations


Authors

Showing all 7146 results

NameH-indexPapersCitations
Eric S. Lander301826525976
Albert Hofman2672530321405
Frank B. Hu2501675253464
David J. Hunter2131836207050
Kari Stefansson206794174819
Mark J. Daly204763304452
Lewis C. Cantley196748169037
Matthew Meyerson194553243726
Gad Getz189520247560
Stacey Gabriel187383294284
Stuart H. Orkin186715112182
Ralph Weissleder1841160142508
Chris Sander178713233287
Michael I. Jordan1761016216204
Richard A. Young173520126642
Network Information
Related Institutions (5)
Howard Hughes Medical Institute
34.6K papers, 5.2M citations

96% related

Salk Institute for Biological Studies
13.1K papers, 1.6M citations

94% related

Fred Hutchinson Cancer Research Center
30.9K papers, 2.2M citations

93% related

Scripps Research Institute
32.8K papers, 2.9M citations

93% related

Genentech
17.1K papers, 1.4M citations

93% related

Performance
Metrics
No. of papers from the Institution in previous years
YearPapers
202337
2022628
20211,727
20201,534
20191,364
20181,107